NCT03924336

Brief Summary

To assess the effectiveness of advanced PRF+ as compared to open flap debridement in treatment of periodontal intraosseous defects in stage III periodontitis patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 17, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 23, 2019

Completed
5 months until next milestone

Study Start

First participant enrolled

September 30, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 7, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 7, 2021

Completed
Last Updated

April 22, 2022

Status Verified

December 1, 2021

Enrollment Period

1.9 years

First QC Date

April 17, 2019

Last Update Submit

April 17, 2022

Conditions

Keywords

stage 3 periodontitisA-PRFAdvanced platelet rich fibrinopen flap debridementOFD2-wall intraosseous defect3-wall intraosseous defect

Outcome Measures

Primary Outcomes (1)

  • Clinical Attachment Level (CAL) gain

    Clinical Attachment Level (CAL) will be measured from the cemento enamel junction (CEJ) to the bottom of the gingival sulcus/periodontal pocket using University of North Carolina (UNC) periodontal probe at six sites per tooth

    Change from Baseline Clinical Attachment Level (CAL) at 9 months

Secondary Outcomes (3)

  • Probing Depth (PD)

    Probing Depth will be measured at base line,3,6, and 9 months postoperative

  • Radiographic defect fill

    Radiographic defect fill will be measured at 6,9,months

  • Gingival Recession Depth (RD)

    Gingival Recession Depth will be measured at base line,3,6, and 9 months postoperative

Study Arms (2)

Advanced- platelets rich fibrin plus with open flap debridement

EXPERIMENTAL

Mucoperiosteal flaps will be elevated using an intrasulcular incision buccally and palatally or lingually. Then the defects will be thoroughly debrided using curettes and ultrasonic scalers. The clinical measurements will be then recorded. After debridement and intraoperative recordings, A-PRF+ of the required size will be filled into the intraosseous defect, the mucoperiosteal flaps will be repositioned and secured in place using 4-0 silk sutures

Procedure: Advanced- platelets rich fibrin (A-PRF+) + Open flap debridement (OFD)

Open flap debridement (OFD)

ACTIVE COMPARATOR

Mucoperiosteal flaps will be elevated using an intrasulcular incision buccally and palatally or lingually. Then the defects will be thoroughly debrided using curettes and ultrasonic scalers. The clinical measurements will be then recorded. After debridement and intraoperative recordings, The interrupted sutures using 4-0 silk sutures will be placed to reposition the flaps.

Procedure: Open flap debridement (OFD) alone

Interventions

Elevation of flap.Thorough debridement of the defects using curettes and ultrasonic scalers. Clinical measurements will be then recorded , A-PRF+ of the required size will be filled into the intraosseous defect. The mucoperiosteal flaps will be repositioned and secured in place using4-0 silk sutures

Advanced- platelets rich fibrin plus with open flap debridement

Elevation of flap.Thorough debridement of the defects using curettes and ultrasonic scalers. Clinical measurements will be then recorded. After debridement and intraoperative recordings, interrupted sutures using 4-0 silk sutures will be placed to reposition the flaps.

Open flap debridement (OFD)

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Stage III periodontitis patient having at least one tooth with 2-wall, 3-wall, or combined 2- to 3-wall intraosseous defect ≥ 3 mm in depth (assessed by bone sounding, radiographic examination) with clinical attachment level (CAL) ≥ 5mm and pocket depth (PD) ≥ 6 mm.
  • Defect not extending to a root furcation area
  • Non-smokers.
  • No history of intake of medications affecting the periodontium in the previous 6 months.
  • Able to sign an informed consent form.
  • Patients age between 18 and 60 years old.
  • Patients who are cooperative, motivated, and hygiene conscious.
  • Systemically free according to Cornell Medical Index (Broadbent, 1951).

You may not qualify if:

  • Pregnancy or breast feeding
  • The presence of an orthodontic appliance
  • Teeth mobility greater than grade I

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry Cairo University

Cairo, 12613, Egypt

Location

Related Publications (2)

  • Cortellini P, Tonetti MS. Clinical concepts for regenerative therapy in intrabony defects. Periodontol 2000. 2015 Jun;68(1):282-307. doi: 10.1111/prd.12048.

  • Kobayashi E, Fluckiger L, Fujioka-Kobayashi M, Sawada K, Sculean A, Schaller B, Miron RJ. Comparative release of growth factors from PRP, PRF, and advanced-PRF. Clin Oral Investig. 2016 Dec;20(9):2353-2360. doi: 10.1007/s00784-016-1719-1. Epub 2016 Jan 25.

MeSH Terms

Conditions

Periodontitis

Interventions

Single Person

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

Marital StatusFamily CharacteristicsDemographyPopulation CharacteristicsSocioeconomic Factors

Study Officials

  • Manal Hosny, Professor

    Cairo University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Due to the type of intervention only the outcome assessor and the statistician will be blinded.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 17, 2019

First Posted

April 23, 2019

Study Start

September 30, 2019

Primary Completion

September 7, 2021

Study Completion

September 7, 2021

Last Updated

April 22, 2022

Record last verified: 2021-12

Locations